SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Wells Fargo Maintains Axogen at Overweight, Raises Target to $56

Wells Fargo maintained its Overweight rating and raised its Axogen price target to $56 from $48.

AXGN

Story updates

02:17:39 PM UTC
SquawkNews
Axogen Is Maintained at Overweight by Wells Fargo

Related stories